Skip to main content

Month: May 2022

Ascendis Pharma A/S to Present New Endocrinology Results at Four Medical Meetings in May

New data highlights include: – Phase 3 open-label extension study data for growth hormone-deficient children treated for 2.5 years with TransConTM hGH – Initial findings from research on comorbidities associated with adult growth hormone deficiency COPENHAGEN, Denmark, May 01, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the company will present clinical and research outcomes and host informational booths and events at four medical meetings during May. Topics will include new open-label extension data for children with growth hormone deficiency treated with TransCon hGH for 2.5 years; research findings showing comorbidities associated with adult growth hormone deficiency; and presentations of TransCon PTH Phase 2 patient-reported health, quality-of-life, and Week 84 data in adult...

Continue reading

Total number of voting rights and share capital in GN Store Nord

In accordance with Section 32 of the Danish Capital Markets Act, GN Store Nord is required to publish the total number of voting rights and the size of the share capital in the company as per the end of a month during which changes have occurred. Referring to company announcement no. 8 of April 7, 2022, as per April 30, 2022, the share capital of GN Store Nord is nominally DKK 548,773,512 divided into shares of DKK 4 each, corresponding to 137,193,378 shares. The total voting rights in the company are 548,773,512. For further information, please contact: Investors and analystsHenriette WennickeVice President – Investor Relations & TreasuryTel: +45 45 75 03 33 or Rune SandagerDirector – Investor Relations & Treasury  Tel: +45 45 75 92 57 Press and the media Lars Otto Andersen-Lange Head of Media Relations & Corporate Public...

Continue reading

Li Auto Inc. April 2022 Delivery Update

BEIJING, May 01, 2022 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company delivered 4,167 Li ONEs in April 2022. Cumulative deliveries of Li ONE have reached 159,971 since the vehicle’s market debut in 2019. “The COVID-19 resurgence in the Yangtze Delta region continues to cause severe industry-wide disruptions in supply chain, logistics and production since late March. Our Changzhou manufacturing base is located in the center of the Yangtze Delta region, which is home to over 80% of our parts suppliers, especially in Shanghai and Kunshan. The COVID-19 resurgence in this area has incapacitated some suppliers in Shanghai and Kunshan. Some of them completely shut down production or delivery of their products, making...

Continue reading

NIO Inc. Provides April 2022 Delivery Update

NIO ET5 First NIO ET5 tooling trial builds rolled off the production lineNIO delivered 5,074 vehicles in April 2022 NIO delivered 30,842 vehicles year-to-date in 2022, increasing by 13.5% year-over-year Cumulative deliveries of vehicles as of April 30, 2022 reached 197,912SHANGHAI, China, May 01, 2022 (GLOBE NEWSWIRE) — NIO Inc. (“NIO” or the “Company”) (NYSE: NIO; HKEX: 9866), a pioneer and a leading company in the premium smart electric vehicle market, today announced its April 2022 delivery results. NIO delivered 5,074 vehicles in April 2022. The deliveries consisted of 4,381 premium smart electric SUVs, including 1,251 ES8s, 1,878 ES6s and 1,252 EC6s, and 693 ET7s, the Company’s flagship premium smart electric sedan. As of April 30, 2022, cumulative deliveries reached 197,912 vehicles. In late March and April 2022, the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.